In short. Oral antibiotics, hormonal agents, and isotretinoin as treatment classes: when each is justified, and the monitoring each one requires.
Key points
- Before starting: pregnancy testing where applicable, blood tests, and a full review of medicines and history.
- During treatment: pregnancy prevention and testing where relevant, periodic blood tests, and review of side effects and mental health.
- A cumulative target dose is planned rather than an open-ended course, and treatment stops if the risks outweigh the benefit.
Oral treatment is used when acne is moderate to severe, widespread, resistant to properly used topical treatment, or already producing scars. It is not a shortcut and it is not a first step. Three families matter: oral antibiotics, hormonal agents in women, and isotretinoin. Each has a specific place, and each carries obligations, whether monitoring, limits on duration, or both.
Oral antibiotics
Oral antibiotics reduce inflamed lesions by suppressing the bacteria involved and by reducing inflammation directly. They work faster than topicals and are useful for a defined period. They are not a long-term solution: courses are kept short, and they are used together with a topical retinoid and benzoyl peroxide rather than alone. The reason is resistance, both in the bacteria on the skin and in the wider problem of unnecessary antibiotic use. They are avoided where possible during pregnancy.
Hormonal agents
In women with a hormonal acne pattern, certain combined oral contraceptives and specific anti-androgen agents reduce sebum production and improve acne. They are genuinely effective and genuinely need individual selection: suitability depends on age, smoking status, blood pressure, migraine history, clotting risk, and plans for pregnancy. Anti-androgen agents require reliable contraception because of their effects on fetal development. These are long-term treatments, and their benefit stops when they stop.
Isotretinoin
Isotretinoin is the most effective treatment available for severe, nodular, or scarring acne, and the only one that can produce prolonged clearance. It also carries the most serious risk profile of any routine acne treatment, and honesty about this matters more than enthusiasm. It causes severe fetal harm, so pregnancy prevention is mandatory and strictly monitored. It commonly causes dry skin and lips, dry eyes, nosebleeds, muscle and joint aches, and raised blood fats and liver enzymes, and it requires blood monitoring before and during treatment. Effects on mood are debated and difficult to predict, and they are taken seriously in monitoring. Uncommon but serious risks also exist, and a prescriber discusses them individually.
What monitoring actually involves
Before starting: pregnancy testing where applicable, blood tests, and a full review of medicines and history. During treatment: pregnancy prevention and testing where relevant, periodic blood tests, and review of side effects and mental health. A cumulative target dose is planned rather than an open-ended course, and treatment stops if the risks outweigh the benefit. No dose decision comes from a leaflet or a website; it is made in a consultation.
Choosing between them
The choice depends on severity, pattern, whether scarring is occurring, sex, reproductive plans, and previous treatment history. Many patients who need oral treatment start with a defined antibiotic course and move to isotretinoin if the response is inadequate; that is a plan, not a failure. Whatever the choice, expectations should be set honestly: oral treatment usually works within a few months, results vary between individuals, relapse after stopping is common, and no oral treatment suits everybody.
Discuss urgently if
- You could be pregnant, or are planning pregnancy, while taking or about to start isotretinoin or an anti-androgen agent.
- You develop severe headache, visual disturbance, sudden muscle pain, or a significant mood change while on oral treatment.
- You notice jaundice, dark urine, or severe abdominal pain during treatment — these need prompt review.
Frequently asked questions
When is oral acne treatment justified?
Oral treatment is used when acne is moderate to severe, widespread, resistant to properly used topical treatment, or already producing scars. It is not a shortcut and it is not a first step, and each family of medicines has a specific place and its own obligations.
Why are oral antibiotics not a long-term acne treatment?
They reduce inflamed lesions and work faster than topicals, but courses are kept short and are used together with a topical retinoid and benzoyl peroxide rather than alone. The reason is resistance, both in the bacteria on the skin and in the wider problem of unnecessary antibiotic use.
What monitoring does isotretinoin require?
It causes severe fetal harm, so pregnancy prevention is mandatory and strictly monitored. Blood tests are taken before and during treatment, side effects and mental health are reviewed, and a cumulative target dose is planned rather than an open-ended course. Uncommon serious risks are discussed individually.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.